These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 34975143)

  • 1. Heparin-induced hyponatremia in COVID-19: A latent culprit!
    Panda R; Singh P; Kodamanchili S; Anand A
    Indian J Pharmacol; 2021; 53(6):515-516. PubMed ID: 34975143
    [No Abstract]   [Full Text] [Related]  

  • 2. A Ghana-UK haematology "heparin" partnership.
    Olayemi E; Davies R; Bates I
    Br J Haematol; 2020 Nov; 191(3):e96-e97. PubMed ID: 32798238
    [No Abstract]   [Full Text] [Related]  

  • 3. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
    Roncon L; Zuin M; Rigatelli G
    Intern Emerg Med; 2021 Mar; 16(2):517-518. PubMed ID: 32378044
    [No Abstract]   [Full Text] [Related]  

  • 4. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
    Allione A; Giamello JD; Paglietta G; Bernardi S; Cavalot G
    Intern Emerg Med; 2021 Mar; 16(2):519-520. PubMed ID: 32440985
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin-induced hyponatremia.
    Norman NE; Sneed AM; Brown C; Ellis CA; Minard G; Brown RO
    Ann Pharmacother; 2004 Mar; 38(3):404-7. PubMed ID: 14742828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study.
    Di Micco P; Tufano A; Cardillo G; Imbalzano E; Amitrano M; Lodigiani C; Bellizzi A; Camporese G; Cavalli A; De Stefano C; Russo V; Voza A; Perrella A; Prandoni P
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
    Zarychanski R; Lawler PR; Goligher E
    N Engl J Med; 2021 Nov; 385(21):2014. PubMed ID: 34788517
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-Induced Thrombocytopenia in Severe COVID-19.
    Daviet F; Guervilly C; Baldesi O; Bernard-Guervilly F; Pilarczyk E; Genin A; Lefebvre L; Forel JM; Papazian L; Camoin-Jau L
    Circulation; 2020 Nov; 142(19):1875-1877. PubMed ID: 32990022
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage.
    Stillson JE; Bunch CM; Gillespie L; Khan R; Wierman M; Pulvirenti J; Phyu H; Anderson S; Al-Fadhl M; Thomas AV; Kwaan HC; Moore E; Moore H; Walsh MM
    Semin Thromb Hemost; 2021 Jun; 47(4):442-446. PubMed ID: 33607668
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients.
    Preti PS; Russo M; Caneva L; Reduzzi M; Calabretta F; Spataro C; Grimaldi P; De Amici M; Testa G; Iotti GA; Mojoli F; Di Sabatino A
    Thromb Res; 2021 Jul; 203():33-35. PubMed ID: 33915353
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin-induced persistent hyperthermia with recurrent hyponatremia in hip fracture: Case report and review of literature.
    Huang Z; Wu X; Zhang S; Liu Z; Guo Q; Ouyang Y; Wang H; Lin W; Song Y
    J Clin Pharm Ther; 2022 Nov; 47(11):1888-1891. PubMed ID: 36222222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    Sterpetti AV
    N Engl J Med; 2021 Nov; 385(21):2013-2014. PubMed ID: 34788516
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    Fernandes TM; McGuire WC; Morris TA
    N Engl J Med; 2021 Nov; 385(21):2013. PubMed ID: 34788515
    [No Abstract]   [Full Text] [Related]  

  • 15. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy.
    Rhoades R; Leong R; Kopenitz J; Thoma B; McDermott L; Dovidio J; Barletti S; Gong JZ; Massey HT; McKenzie SE; Rame JE; Al-Rawas N
    Thromb Res; 2021 Jul; 203():1-4. PubMed ID: 33894473
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune heparin-induced thrombocytopenia: a rare manifestation of COVID-19.
    Julian K; Bucher D; Jain R
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34031097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC135. PubMed ID: 34871054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
    Ogawa Y; Nagata T; Akiyama T; Nishida K; Kumasawa J; Kohno M; Kohata H; Gohma I
    J Thromb Thrombolysis; 2020 Nov; 50(4):1012-1014. PubMed ID: 32780355
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous Muscle Hematoma in Japanese Patients with Severe COVID-19 Treated with Unfractionated Heparin: Two Case Reports.
    Ito Y; Awano N; Uchiyama F; Inomata M; Kuse N; Tone M; Takada K; Fujimoto K; Muto Y; Sagisaka S; Maki K; Yamashita R; Harada A; Nishimura JI; Hayashi M; Izumo T
    Intern Med; 2021 Nov; 60(21):3503-3506. PubMed ID: 34433713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-Induced Thrombocytopenia in COVID-19.
    Lingamaneni P; Gonakoti S; Moturi K; Vohra I; Zia M
    J Investig Med High Impact Case Rep; 2020; 8():2324709620944091. PubMed ID: 32720827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.